MT Newswires on MSN2d
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.22% to 1,373.53 on the S&P Europe Select ADR Index. From continental Europe, the gainers ...
Buy Rating Reaffirmed for Sarepta Therapeutics Following Positive EMBARK Study Results
Analyst Gil Blum from Needham maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) and keeping the price target at ...
20,000 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Acquired by Arkadios Wealth Advisors
Arkadios Wealth Advisors acquired a new position in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) during the ...
Autolus Therapeutics (AUTL) Gets a Buy from Truist Financial
In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Autolus Therapeutics (AUTL – Research ...
Investing15d
Autolus presents new data on CAR-T therapy cost benefits
LONDON - Autolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company specializing in T cell therapies for cancer, has announced its participation in the upcoming 2025 Tandem Meetings | ...
Taiwan News16d
Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
LONDON, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T ...
Nasdaq16d
Autolus Therapeutics to Present Data at 2025 Tandem Meetings on AUCATZYL® and Its Economic Impact Compared to CAR-T Therapies
Autolus Therapeutics received acceptance for an oral presentation and three poster presentations at the prestigious 2025 Tandem Meetings, highlighting their commitment to disseminating research ...